Introduction
Lactogenesis or the onset of milk synthesis is a two stage process in rats that occurs during late pregnancy (Fleet et al, 1975 (Topper and Freeman, 1980) . However, the unequivocal role of a particular hormone in mammary gland differentiation is difficult to ascertain, due to the interactions between the hormones. Apart from its own particular action, each hormone modulates the secretion or the effects of the others.
A number of studies have indicated that some growth factors are involved in the differentiation of the mammary gland. Among them, insulin-like growth factors (IGFs) and epidermal growth factor (EGF) play a major role in this process (Dembinski and Shiu, 1987) .
Serum concentrations of EGF increase during pregnancy in mice (Dembinski and Shiu, 1987) , and studies in vitro have shown the mitogenic effects of EGF on the mammary epithelial cells of humans (Papadimitriou et al, 1977) and mice (Turkington, 1969) . The effect of EGF on milk protein synthesis in vitro is controversial. Initially, an inhibitory effect in a dose-dependent manner was reported (Taketani and Oka, 1983) . However, when EGF was given in the presence of a physiological insulin concentration, there was no effect on casein synthesis (Sankaran and Topper, 1987) .
The biological actions of EGF are mediated by a specific receptor which has protein tyrosine kinase activity and is located on the cell membrane (Carpenter and Cohen, 1979 (Edery et al, 1985) .
The mitogenic effect of IGF-I was observed in a human breast cancer cell line (Myal et al, 1984) and in mammary cells from mice (Imagawa et al, 1986) . IGF-I is believed to mediate
The effect of IGFs is initiated by the specific binding to their cell-surface receptors. The type I receptor has a high affinity for IGF-I and a lower affinity for IGF-II and insulin (Kasuga et al, 1981) . The type II receptor which has a higher affinity for IGF-II than for IGF-I and does not bind insulin was recently identified as the mannose 6-phosphate receptor (MacDonald el al, 1988) .
The trigger for lactogenesis at the end of pregnancy is the fall in circulating concentrations of progesterone, which allows the differentiated mammary gland to begin milk synthesis (Kuhn, 1969 (Molinolo et al, 1987) or radioreceptor assay (Elizalde et al, 1990a) . The sensitivities of the assays were 10 pg and 150 pg, respectively.
Iodination
Labelling of IGF-I, IGF-II and EGF with 125I was performed by the chloramine-T method, followed by purification by Sephadex G-50 chromatography as described by Elizalde et al (1990b of the total radioactivity present. The non-specific binding was subtracted from total binding to obtain specific binding. Scatchard plots (Scatchard, 1949) were used to determine equilibrium constants (K¿) and the number of receptors, using the program ligand (Munson and Rodbard, 1980 (1.1 ± 0.05 (n = 4) and 0.71 ± 0.07 (n = 5) nmol 1 \ respect¬ ively) (Fig. 1) . Receptor concentration was lower in the differentiated gland than in the controls (control 71.2 ±17 (n = 4) fmol mg~ protein; ovariectomized 24.9 ± 7.4 (n = 5) fmol mg~1 protein, < 0.05) and similar to that found in those glands in which lactation was already established (25.7 ± 7 (n = 4) fmol mg~1 protein). (Fig. 4) (Fig. 7) .
Discussion
The results presented here confirm and extend previous studies on changes to Ovariectomy, which induces lactogenesis (Liu and Davis, 1967) , provides an appropriate model of the mammary gland with the same degree of development as that in the intact animal, but that synthesises milk. The biosynthetic activity of the mammary gland induced by ovariectomy is not of the same magnitude as that obtained by the removal of corpora lutea, but leaves the other ovarian functions intact. Replacement therapy with oestrogen is required for the stimulation of ct-lactalbumin activity to be similar to that in the intact animal (Bussmann et al, 1983) , whereas progesterone replacement treatment effectively suppresses milk synthesis induced by ovariectomy (Kuhn, 1969 (Vonderhaar, 1987) indicating that the stimulatory action of progesterone and oestrogen together is due to the regulation of the concen¬ tration of the EGF receptor (Haslam et al, 1992 (Higashiyama et al, 1992) . In the mouse mammary gland, an EGF-like growth factor activity, MDGF, has been described by Vonderhaar (1984) , and the presence of amphiregulin, which binds to the EGF receptor and heparin, was recently reported by Kenney et al (1995) .
The presence of high-affinity binding sites for IGF-I has been reported in rat mammary glands and their concentrations were higher in rats at day 7 of pregnancy compared with virgin or lactating rats (Collier et al, 1989 (Corps and Brown, 1987) , and immunohistochemical studies have shown that in rat mammary glands IGF-I is present only in myoepithelial cells (Marcotty et al, 1994) . Downregulation of the IGF-I receptor during lactogenesis could indicate the uptake and transfer of the growth factor from the myoepithelial cells or serum to milk, as described in goats (Prosser et al, 1991 (Hadsell et al, 1994) . Recently, the IGF-II receptor was confirmed as being identical to the mannose 6-phosphate receptor (MacDonald et al, 1988 ) which targets acid hydrolases to lysosomes (Pfeffer, 1988 
